European Study Data To Impact Boston Scientific Brachytherapy Trial Design
This article was originally published in The Gray Sheet
Executive Summary
Results from a recent European trial of Boston Scientific's beta-radiation system showing that a radiation dose of 18 Gray (Gy) led to less restenosis compared to lower doses will help the firm design the protocol of upcoming U.S. studies, the company says.